Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
immuno-suppresant agent More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 124 pages - $1,740
Nov 2010 - 85 pages - $3,500
Jun 2009 - 110 pages - $1,040
Jun 2008 - 175 pages - $3,835
Jan 2007 - 126 pages - $2,495
Jul 2011 - 147 pages - $3,835
Jan 2011 - 231 pages - $3,835
Nov 2010 - 40 pages - $500
Apr 2010 - 347 pages - $3,835
Jan 2011 - 34 pages - $500
Your selection
Browse By
- Industry sector
- Cachet
- Capsule
- Chewing gum
- Granule/Powder
- Lozenge
- Other
- Sustained Release
- Sweet/Candy/Bonbon
- Tablet
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us